Le Lézard
Classified in: Health
Subjects: POLITICS, HEALTH, GOVERNMENT CONTRACTS, MISCELLANEOUS

RTOERO urges collective action towards sustainable, just future at federal advocacy event


Toronto, April 26, 2023 (GLOBE NEWSWIRE) -- RTOERO volunteers and staff met with federal MPs and government officials during its second Advocacy on the Hill event on April 24 and 25. During virtual meetings both days and an in-person reception on April 25, RTOERO Board of Directors, Political Advocacy Committee members and senior staff dialogued with MPs and government staff about RTOERO's key advocacy issues:

"The pandemic magnified the pre-existing fractures in our social service structure?for older adults and other vulnerable groups," says Martha Foster, chair of RTOERO's Board of Directors. "We have an opportunity now to work together and rebuild the system collaboratively?we can't squander this chance."

RTOERO white papers on its key issues were shared with MPs and staff covering various ministries. RTOERO offered its expertise and insight to help improve the lives of seniors in Canada. The RTOERO team urged officials and MPs to take collective action toward a more sustainable and just future for all Canadians.

Notes Foster, "RTOERO members, and many Canadians, want and expect change, and we want to be part of it. The question is, collectively, what legacy do we want to leave? What really matters?"

In addition to advocacy, RTOERO focuses several initiatives on these key priority areas, including:

 

About RTOERO

RTOERO is a bilingual trusted voice on healthy, active living in the retirement journey for the broader education community. With 83,000+ members in 51 districts across Canada, we are the largest national provider of non-profit group health benefits for education retirees. We welcome members who work in or are retired from the early years, schools and school boards, post-secondary and any other capacity in education. We believe in a better future, together!

Attachments



These press releases may also interest you

at 09:19
NeuroSense Therapeutics Ltd. ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update. Corporate Highlights from Q1 2024 and To Date Merit Cudkowicz, M.D., M.Sc., chair of...

at 09:18
Inspiratm Technologies OXY B.H.N. Ltd. (the "Company" or "Inspira"), a breakthrough medical technology company, announced the start of production of the INSPIRA ART100 medical device. The INSPIRA ART100 device is being contract manufactured by a...

at 09:15
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced the first commercial placement of the REM-I platform at Erasmus Medical Center in Rotterdam. This commercial...

at 09:15
DoseMe, a leading provider of model-informed precision dosing (MIPD) software, has announced its collaboration with Excela Health, now part of Independence Health System. This alliance will advance therapeutic drug monitoring and optimize...

at 09:15
RenovoRx, Inc. ("RenovoRx" or the "Company") , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Shaun R. Bagai, Chief Executive Officer, will...

at 09:15
Mekonos, Inc., a biotech platform company building the future of cell engineering on a chip, today announced it has entered into a partnership agreement with Accelerated Biosciences Corp. ("Accelerated Bio") to codevelop a powerful, new manufacturing...



News published on and distributed by: